Product Details
ENVARSUS XR- tacrolimus tablet, extended release 4mg
Manufacturer: Veloxis Pharmaceuticals, Inc
MFG#: 68992-3040-01
NDC: 68992-3040-01
PID: 425793
Description
Indications and Usage:
1.1 Prophylaxis of Organ Rejection in De Novo Kidney Transplant Patients
ENVARSUS XR is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants [see Clinical Studies (14.1)].
1.2 Prophylaxis of Organ Rejection in Stable Kidney Transplant Patients Converting from Immediate-Release Formulations
ENVARSUS XR is indicated for the prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations, in combination with other immunosuppressants [see Clinical Studies (14.2)].
Frequently Asked Questions (FAQs)
The cost of ENVARSUS XR- tacrolimus tablet, extended release 4mg is $available for registerd members only
ENVARSUS XR- tacrolimus tablet, extended release 4mg is manufactured by Veloxis Pharmaceuticals, Inc .
You can purchase ENVARSUS XR- tacrolimus tablet, extended release 4mg on our website at https://supplies.pipelinemedical.com/product/detail/envarsus-xr-tacrolimus-tablet-extended-release-4mg-425793